Skip to main content

hTERT ICC Test

A product by BARD1

BARD1 Life Sciences Ltdis a leading Australian-based medical diagnostics company with a deep portfolio of innovative cancer diagnostic technologies and products. The company’s programs are focussed on the development and commercialisation of diagnostic tests for early detection of cancer including ovarian, breast, lung, prostate, bladder and pancreatic cancers.